Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen A Boorjian

Showing results (1-10 of 550) with videos related to

Pageof 55
Sort By:
European Urology|July 1, 2011
Postoperative intravesical therapy to prevent bladder tumor recurrence: are we ready to listen yet?Stephen A Boorjian
European Urology|March 12, 2015
Words of wisdom. Re: Overall survival advantage with partial nephrectomy: a bias of observational data?Stephen A Boorjian
The Journal of Urology|March 23, 2010
Editorial commentStephen A Boorjian
The Journal of Urology|July 24, 2012
Trends in minimally invasive surgery for the kidney and prostate--when are you doing the patient a disservice by not referring?Stephen A Boorjian
The Journal of Urology|December 17, 2009
Editorial commentStephen A Boorjian
European Urology|September 12, 2016
Primum Non Nocere: Critically Assessing the Morbidity of Prostate BiopsyBoris Gershman, Stephen A Boorjian
European Urology|March 28, 2021
When Less Is More: The Comparative Effectiveness of Partial Versus Radical NephrectomyBoris Gershman, Stephen A Boorjian
European Urology|December 17, 2017
Reply to Georgios Papadopoulos, Charalampos Fragkoulis, and Konstantinos Ntoumas' Letter to the Editor re: Bimal Bhindi, Igor Frank, Ross J. Mason, et al. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Eur Urol 2017;72:660-4Bimal Bhindi, Stephen A Boorjian
European Urology|November 4, 2017
Reply to Giulia I. Lane and Badrinath Konety's Letter to the Editor re: Bimal Bhindi, Igor Frank, Ross J. Mason, et al. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Eur Urol 2017;72:660-4Bimal Bhindi, Stephen A Boorjian
Urologic Oncology|December 3, 2014
Radical prostatectomy in high-risk and locally advanced prostate cancer: Mayo Clinic perspectiveSuzanne B Stewart, Stephen A Boorjian
Pageof 55

Showing results (1-10 of 550) with videos related to

Sort By:
Pageof 55
European Urology|July 1, 2011
Postoperative intravesical therapy to prevent bladder tumor recurrence: are we ready to listen yet?Stephen A Boorjian
European Urology|March 12, 2015
Words of wisdom. Re: Overall survival advantage with partial nephrectomy: a bias of observational data?Stephen A Boorjian
The Journal of Urology|March 23, 2010
Editorial commentStephen A Boorjian
The Journal of Urology|July 24, 2012
Trends in minimally invasive surgery for the kidney and prostate--when are you doing the patient a disservice by not referring?Stephen A Boorjian
The Journal of Urology|December 17, 2009
Editorial commentStephen A Boorjian
European Urology|September 12, 2016
Primum Non Nocere: Critically Assessing the Morbidity of Prostate BiopsyBoris Gershman, Stephen A Boorjian
European Urology|March 28, 2021
When Less Is More: The Comparative Effectiveness of Partial Versus Radical NephrectomyBoris Gershman, Stephen A Boorjian
European Urology|December 17, 2017
Reply to Georgios Papadopoulos, Charalampos Fragkoulis, and Konstantinos Ntoumas' Letter to the Editor re: Bimal Bhindi, Igor Frank, Ross J. Mason, et al. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Eur Urol 2017;72:660-4Bimal Bhindi, Stephen A Boorjian
European Urology|November 4, 2017
Reply to Giulia I. Lane and Badrinath Konety's Letter to the Editor re: Bimal Bhindi, Igor Frank, Ross J. Mason, et al. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Eur Urol 2017;72:660-4Bimal Bhindi, Stephen A Boorjian
Urologic Oncology|December 3, 2014
Radical prostatectomy in high-risk and locally advanced prostate cancer: Mayo Clinic perspectiveSuzanne B Stewart, Stephen A Boorjian
Pageof 55